Human neural precursor cells express functional kappa-opioid receptors.

Neural stem cells (NSCs) play an important role in the developing as well as adult brain. NSCs have been shown to migrate toward sites of injury in the brain and to participate in the process of brain repair. Like NSCs, cultured human neural precursor cells (NPCs) are self-renewing, multipotent cells capable of differentiating into neurons, astrocytes, and oligodendrocytes and of migrating toward chemotactic stimuli. Cellular and environmental factors are important for NPC proliferation and migration. Expression of kappa-opioid receptors (KORs) and mu-opioid receptors (MORs) in murine embryonic stem cells and of MORs and delta-opioid receptors in rodent neuronal precursors, as well as hippocampal progenitors has been reported by other investigators. In this study, we demonstrated robust expression of KORs in highly enriched (>90% nestin-positive) human fetal brain-derived NPCs. We found that KOR ligands, dynorphin(1-17) and trans-3,4-dichloro-N-methyl-N[2-(1-pyrolidinyl)cyclohexyl] benzeneacetamide methanesulfonate (U50,488) but not dynorphin(2-17), stimulated proliferation and migration of NPCs in a concentration-dependent manner. NPC proliferation was maximally stimulated at 10(-14) M dynorphin(1-17) and 10(-12) M U50,488. The KOR selective antagonist, nor-binaltorphimine, partially blocked the migratory and proliferative effects of KOR agonists supporting, at least in part, the involvement of a KOR-related mechanism. As has been described for rodent P19 embryonal carcinoma stem cells, retinoic acid treatment markedly suppressed KOR mRNA expression in human NPCs. Taken together, the results of this study suggest that activation of KORs alters functional properties of NPCs/NSCs that are relevant to human brain development and repair.

[1]  Y. Hurd,et al.  Discrete opioid gene expression impairment in the human fetal brain associated with maternal marijuana use , 2006, The Pharmacogenomics Journal.

[2]  J. Crandall,et al.  Retinoic acid signaling and function in the adult hippocampus. , 2006, Journal of neurobiology.

[3]  F. Gage,et al.  Retinoic acid is required early during adult neurogenesis in the dentate gyrus. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[4]  G. Koob,et al.  Kappa opioid control of seizures produced by a virus in an animal model. , 2006, Brain : a journal of neurology.

[5]  M. Cheeran,et al.  High-level expression of functional chemokine receptor CXCR4 on human neural precursor cells. , 2004, Brain research. Developmental brain research.

[6]  S. Negus.  Effects of the kappa opioid agonist U50,488 and the kappa opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeys , 2004, Psychopharmacology.

[7]  G. Koob,et al.  Epilepsy, CNS viral injury and dynorphin. , 2004, Trends in pharmacological sciences.

[8]  M. Maden,et al.  Too much of a good thing: retinoic acid as an endogenous regulator of neural differentiation and exogenous teratogen , 2003, The European journal of neuroscience.

[9]  P. Eriksson,et al.  Opioid-induced proliferation through the MAPK pathway in cultures of adult hippocampal progenitors , 2003, Molecular and Cellular Neuroscience.

[10]  P. Eriksson,et al.  Mu‐ and delta‐opioid receptor antagonists decrease proliferation and increase neurogenesis in cultures of rat adult hippocampal progenitors , 2003, The European journal of neuroscience.

[11]  H. Loh,et al.  Regulation of opioid receptor expression. , 2002, Current opinion in pharmacology.

[12]  M. Barrot,et al.  Opiates inhibit neurogenesis in the adult rat hippocampus. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Elde,et al.  Opioids intrinsically inhibit the genesis of mouse cerebellar granule neuron precursors in vitro: differential impact of μ and δ receptor activation on proliferation and neurite elongation , 2000, The European journal of neuroscience.

[14]  K. Yarygin,et al.  Non-opioid dynorphin binding site on secretory vesicles of a pituitary-derived cell line , 1998, Brain Research.

[15]  J. Pintar,et al.  Developmental Expression of the μ, κ, and δ Opioid Receptor mRNAs in Mouse , 1998, The Journal of Neuroscience.

[16]  T. Shippenberg,et al.  kappa-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine. , 1996, The Journal of pharmacology and experimental therapeutics.

[17]  T. Shippenberg,et al.  Development of behavioral sensitization to cocaine: influence of kappa opioid receptor agonists. , 1995, The Journal of pharmacology and experimental therapeutics.

[18]  Z. Vogel,et al.  Dynorphins Modulate DNA Synthesis in Fetal Brain Cell Aggregates , 1995, Journal of neurochemistry.

[19]  S. D. Glick,et al.  Kappa opioid inhibition of morphine and cocaine self-administration in rats , 1995, Brain Research.

[20]  H. Loh,et al.  The kappa-opioid receptor is primarily postsynaptic: combined immunohistochemical localization of the receptor and endogenous opioids. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Rowiński,et al.  K‐Opioid Agonist Modulation of [3H]Thymidine Incorporation into DNA: Evidence for the Involvement of Pertussis Toxin‐Sensitive G Protein‐Coupled Phosphoinositide Turnover , 1993, Journal of neurochemistry.

[22]  R. Wesselschmidt,et al.  Mu- and kappa-opioids induce the differentiation of embryonic stem cells to neural progenitors. , 2006, The Journal of biological chemistry.

[23]  M. Narita,et al.  Role of delta-opioid receptor function in neurogenesis and neuroprotection. , 2006, Journal of neurochemistry.

[24]  H. Loh,et al.  Retinoic acid-induced chromatin remodeling of mouse kappa opioid receptor gene. , 2005, Journal of Neuroscience.

[25]  T. Nabeshima,et al.  Alpha 7-type nicotinic acetylcholine receptor and prodynorphin mRNA expression after administration of (-)-nicotine and U-50,488H in beta-amyloid peptide (25-35)-treated mice. , 2004, Annals of the New York Academy of Sciences.

[26]  H. Loh,et al.  Regulation of mouse kappa opioid receptor gene expression by retinoids. , 2001, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[27]  R. Elde,et al.  Stimulus-dependent translocation of kappa opioid receptors to the plasma membrane. , 1999, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[28]  J. Bidlack,et al.  Detection of kappa opioid receptors on mouse thymocyte phenotypic subpopulations as assessed by flow cytometry. , 1998, The Journal of pharmacology and experimental therapeutics.

[29]  J. Buck,et al.  Retinoic acid-induced increase in delta-opioid receptor and N-methyl-D-aspartate receptor mRNA levels in neuroblastoma x glioma (NG108-15) cells. , 1996, Brain research bulletin.

[30]  Lee Nm.  Dynorphin A: a rectifying peptide. , 1995 .